(Q48370760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

M Olga Rojas-Corrales

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Juan A Mico

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

11 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

221-231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-006-0619-5

21 December 2019

exact match

0 references

cites work

Hallucinogens, serotonin and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0619-5

The epidemiology of obsessive-compulsive disorder in five US communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0619-5

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0619-5

"Just right" perceptions associated with compulsive behavior in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0619-5

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0619-5

A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine

21 January 2018

1 reference

12 December 2020

Effects of chronic tramadol on pre- and post-synaptic measures of monoamine function

1 reference

12 December 2020

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study

1 reference

12 December 2020

Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception

1 reference

12 December 2020

Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions

1 reference

12 December 2020

The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome

1 reference

12 December 2020

Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder

1 reference

12 December 2020

The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement.

1 reference

12 December 2020

Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism

1 reference

12 December 2020

Sequential use of opioid antagonists and agonists in Tourette's syndrome

1 reference

12 December 2020

Tramadol induces antidepressant-type effects in mice

1 reference

12 December 2020

Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study

1 reference

12 December 2020

Tourette syndrome: successful treatment with clonidine and oxycodone

1 reference

12 December 2020

Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette's syndrome

1 reference

12 December 2020

Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action

1 reference

12 December 2020

Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates

1 reference

12 December 2020

The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes

1 reference

12 December 2020

New advances in neuroimaging in the diagnosis of obsessive-compulsive disorder

1 reference

12 December 2020

Effects of nicotine on head-shakes and tryptophan metabolites

1 reference

12 December 2020

Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status

1 reference

12 December 2020

A possible new treatment approach to obsessive-compulsive disorder

1 reference

12 December 2020

Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder

1 reference

12 December 2020

1 reference

12 December 2020

Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients

1 reference

12 December 2020

Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.

1 reference

12 December 2020

Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome

1 reference

12 December 2020

Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function

1 reference

12 December 2020

A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome

1 reference

12 December 2020

Naloxone withdrawal exacerbates Tourette syndrome

1 reference

12 December 2020

The efficacy of intramuscular tramadol as a rapid-onset antidepressant

1 reference

12 December 2020

Behavioral evidence for mu-opioid and 5-HT2A receptor interactions

1 reference

12 December 2020

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

12 December 2020

5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation

1 reference

12 December 2020

The genetics of obsessive compulsive disorder and Gilles de la Tourette's syndrome

1 reference

12 December 2020

A review of central 5-HT receptors and their function

1 reference

12 December 2020

Behavioral effects of naloxone infusion in obsessive-compulsive disorder

1 reference

12 December 2020

Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study

1 reference

12 December 2020

Is episodic obsessive compulsive disorder bipolar? A report of four cases

1 reference

12 December 2020

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

1 reference

12 December 2020

Pharmacotherapy for obsessive-compulsive disorder

1 reference

12 December 2020

Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei

1 reference

12 December 2020

The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group

1 reference

12 December 2020

Possible antidepressant activity of methadone.

1 reference

12 December 2020

Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists

1 reference

12 December 2020

Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder

1 reference

12 December 2020

(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists

1 reference

12 December 2020

Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats.

1 reference

12 December 2020

Worsening of obsessive–compulsive symptoms under methadone tapering

1 reference

12 December 2020

The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis

1 reference

12 December 2020

Alpha-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task

1 reference

12 December 2020

Consideration of the relevance of ethological animal models for human repetitive behavioral spectrum disorders

1 reference

12 December 2020

Treatment of refractory major depression with tramadol monotherapy.

1 reference

12 December 2020

A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder

1 reference

12 December 2020

Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns?

1 reference

12 December 2020

Tramadol reduces the 5-HTP-induced head-twitch response in mice via the activation of mu and kappa opioid receptors

1 reference

12 December 2020

Naloxone administration in obsessive-compulsive disorder: report of two cases

1 reference

12 December 2020

Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram

1 reference

12 December 2020

Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid

1 reference

12 December 2020

Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders

1 reference

12 December 2020

Mu opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics

1 reference

12 December 2020

Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats

1 reference

12 December 2020

Mapping Structural Brain Alterations in Obsessive-Compulsive Disorder

1 reference

12 December 2020

Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated rats.

1 reference

12 December 2020

Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models

1 reference

12 December 2020

Methadone treatment of Tourette's disorder

1 reference

12 December 2020

Rapid remission of OCD with tramadol hydrochloride.

1 reference

12 December 2020

1 reference

12 December 2020

Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI

1 reference

12 December 2020

Neuroimaging studies of obsessive-compulsive disorder in adults and children

1 reference

12 December 2020

10.1007/S00213-006-0619-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17102981%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference